Effects of Intravenous Administration of Recombinant Human Erythropoietin in Rats Subject to Hemorrhagic Shock

Publisher Website
Google Scholar
Abstract
The effects of recombinant human erythropoietin (rHuEPO) on survival and blood pressure in hypovolemic hemorrhagic shock in rats have been studied by intravenous administration. The hormone caused an increase in the time of survival compared to the group of rats without treatment (102 ± 4.5 vs. 25 ± 4.5 min, p